-
Labubu maker Pop Mart's shares fall 23% despite surging earnings
-
ECB won't be 'paralysed' in face of energy shock: Lagarde
-
Iran hits targets across Middle East after Trump signals talks progress
-
McEvoy says best is to come after breaking long-standing swim record
-
Japan PM asks IEA to prepare additional 'coordinated release' of oil
-
Goat vs gecko: A tiny Caribbean island faces wildlife showdown
-
Japan PM asks IEA chief to prepare additional 'coordinated release' of oil
-
Hungary's hard-pressed LGBTQ people say Orban exit is only half battle
-
Belarus leader visits North Korea for first time
-
'No heavier burden': the decades-long search for Kosovo war missing
-
Exotic pet trade thrives in China despite welfare concerns
-
Iran fires missile salvo after Trump signals progress in talks
-
BTS concert drew 18.4 million viewers, says Netflix
-
OSCE's 'chaotic' Ukraine evacuation put staff at risk: leaked report
-
Top WTO official sounds fertiliser warning over Middle East war
-
France and Brazil weigh up World Cup prospects in glamour friendly
-
Italy hoping to end World Cup pain as play-offs loom
-
Dirty diapers born again in Japan recycling breakthrough
-
Verstappen's Japan GP win streak under threat as Mercedes dominate
-
Crude tumbles, stocks rally on hopes for Iran war de-escalation
-
Sinner powers past Michelsen to reach Miami quarter-finals
-
Gauff outlasts Bencic to reach Miami semi-finals
-
'Hero' Australian dog who saved 100 koalas retires
-
Underdogs chase World Cup berths in Mexico playoff tournament
-
Pope heads to tiny Catholic Monaco
-
Meet the four astronauts set to voyage around the Moon
-
Artemis 2 Moon mission: a primer
-
It's go time: historic Moon mission set for lift-off
-
Denmark's PM Mette Frederiksen, tenacious and tough on migration
-
OpenAI kills Sora video app in pivot toward business tools
-
Danish PM's left-wing bloc wins election, but no majority
-
Brazil court grants house arrest for jailed Bolsonaro
-
Sinner downs Michelsen to reach Miami Open quarter-finals
-
Advantage Arsenal in women's Champions League quarter-final against Chelsea
-
Garner dreams of World Cup glory in bid to replicate England under-21 success
-
New Mexico jury finds Meta liable for endangering children
-
Huge crowd in Buenos Aires marks 50 years since Argentina's coup
-
Oil, stock trading spiked before Trump's Iran remarks
-
Colombia military plane crash death toll rises to 69
-
Trump adds Columbus statue, walkway in latest White House makeover
-
Danish PM's left-wing bloc leads election, but no majority
-
Toronto unveils upgraded World Cup venue after fan scorn
-
Beerensteyn goal gives Wolfsburg edge over Lyon in women's Champions League
-
Gang crackdown carried out without 'abuses,' Guatemalan defense chief says
-
Afghanistan releases detained US citizen
-
Danish PM's left bloc leads election, but no majority
-
'Illustrious' Salah to leave Liverpool at the end of the season
-
Trump says Iran gave US 'gift' linked to Strait of Hormuz
-
US officials downplay controller 'distraction' in New York crash
-
Massive Russian drone attacks kill eight, hit Ukraine UNESCO site
Emigrate or waste away: dilemma for Venezuela multiple sclerosis patients
For Venezuelan Jaimar Tuarez, 22, being diagnosed with multiple sclerosis felt like a death sentence in a country unable to provide the drugs she needs to keep her ever-worsening symptoms at bay.
With no means of paying for private treatment or tests, including a spinal tap that costs $800, the psychology student has launched a crowd-funding campaign on GoFundMe that she hopes will allow her to travel abroad in search of medical help.
"For many people the only option is to emigrate," Tuarez, who was diagnosed in 2022, told AFP at her apartment in Charallave, a city some 50 kilometers (31 miles) from Caracas.
"I have to get out of here..." she said through tears. "What will happen with my next relapse? Will I lose the ability to speak? I am 22 years old... what will happen to all my dreams, my plans?"
The plight of Tuarez and an estimated 2,000 other Venezuelans with MS -- a potentially disabling disease of the central nervous system -- underlines the difficulties facing people in need of chronic medication in cash-strapped Venezuela.
There is no cure, but drugs can alleviate MS symptoms.
According to the Inter-American Commission on Human Rights (IAHCR), Venezuela's IVSS social welfare institute stopped providing prescription MS medication years ago.
Venezuela is in the grips of an unprecedented economic crisis, with its once-thriving oil industry all but collapsed and GDP shrinking by 80 percent in eight years of recession until 2022.
Millions have fled in search of a better life elsewhere, many seeking a path to the United States.
- 'We are adrift -
Tuarez has weakened to the point where she can barely stand, forcing her to abandon her psychology studies and quit her job as an online editor that had helped augment the family income.
Now Tuarez and her mother, a stroke survivor, both depend on the meager income of her 72-year-old grandmother, who works at a beauty salon in the capital.
Andres Marcano, a 53-year-old translator diagnosed with MS two decades ago, told AFP his mobility has drastically deteriorated in the last five years after he stopped receiving state-funded medication.
"I find it difficult to speak. I don't walk. I am unable to stand and therefore I move around in a wheelchair," he told AFP via WhatsApp.
The situation "is serious, we are adrift," said another MS sufferer, Maria Eugenia Monagas, 57, who pays privately for treatment thanks to the income of her husband and two children, one of them abroad.
"Many are disabled, or dead, due to a lack of medicines," she said.
The government of President Nicolas Maduro blames the state's failure on US sanctions. But others point to graft allegations against officials from the health ministry and the IVSS in a country with a long history of corruption and mismanagement, according to international observers.
- No options -
Tuarez said her last relapse left her temporarily unable to speak, walk or eat independently.
She was prescribed steroids to ease the symptoms, but could not get any through the IVSS.
In the private sector, the medicines she needs cost as much as $30,000 per year.
Tuarez said she spent Christmas Eve sending out emails to aid organizations in different countries, seeking help to leave the country with her mother, who needs care and cannot be left behind.
So far, she has collected $600 out of her objective of $10,000.
Tuarez is overwhelmed at the thought of leaving behind her family, a beloved dog and two cats, but fears her life is in danger if she does not.
"I wish there were other options, to make a career and live my life (in Venezuela), but there are none," Tuarez said.
Q.Najjar--SF-PST